Cargando…
Using a fingerstick test for haematological monitoring in patients treated with clozapine
BACKGROUND: Treatment with clozapine requires regular blood monitoring in order to minimise the risk of agranulocytosis. The demands on patients and clinicians associated with monitoring may be reduced by using point-of-care, as opposed to lab-based assessments. We assessed the utility of a device t...
Autores principales: | Atkins, Matthew, McGuire, Philip, Balgobin, Bhirundra, Patel, Pravinkumar, Taylor, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010800/ https://www.ncbi.nlm.nih.gov/pubmed/33854764 http://dx.doi.org/10.1177/20451253211000865 |
Ejemplares similares
-
Clozapine haematological monitoring for neutropenia: a global perspective
por: Oloyede, Ebenezer, et al.
Publicado: (2022) -
O9.1. SATISFACTION WITH USING A NOVEL FINGERSTICK FOR ABSOLUTE NEUTROPHIL COUNT (ANC) AT THE POINT OF TREATMENT IN PATIENTS TREATED WITH CLOZAPINE
por: Kelly, Deanna, et al.
Publicado: (2020) -
Haematological Monitoring in Clozapine Use: Blood Best Sampled in the Afternoon?
por: Ade-Dosumu, Adedoyin, et al.
Publicado: (2022) -
Feasibility of Portable Fingerstick Cholinesterase Testing in
Adolescents in South Texas
por: Trueblood, Amber B., et al.
Publicado: (2019) -
Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study
por: Oloyede, Ebenezer, et al.
Publicado: (2023)